In an ischaemic stroke, the blood flow to the brain is decreased by blockage of a blood vessel. If this is not treated quickly, the brain tissue becomes injured, leading to symptoms, such as changes ...

For stroke patients undergoing mechanical thrombectomy, adjunctive intra ... associated with an increase in mortality or symptomatic intracranial hemorrhaging (sICH). There was, however, an ...

The incidence of intracranial hemorrhage was similar in the two trial groups. These results support the use of alteplase in this extended time window if endovascular thrombectomy is not available.

[57,60] Intracranial angioplasty and stenting is ... Penumbra Stroke System®are US FDA-approved endovascular devices for thrombectomy in acute ischemic stroke due to cerebral vascular occlusions.

For patients with mainly mild posterior circulation ischemic stroke, alteplase administered at 4.5 to 24 hours after onset results in higher frequency of functional independence.

Anaconda Biomed, SL, announced the publication of results of the ANAIS study, which evaluated the safety and performance of the c ...

With the addition of the Pounce™ XL Thrombectomy System, indicated for use in 5.5–10 mm peripheral arteries, the fully mechanical Pounce™ Thrombectomy Platform can now remove thrombi or ...

A new study published in the Journal of American Medical Association showed that stroke recovery was inversely correlated ...

The incidence of symptomatic intracranial hemorrhage within 36 ... use of alteplase in this extended time window if endovascular thrombectomy is not available," the authors write.